Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 23, 2018 Filed Aug 28, 2018 01:34 UTC |
Brister MarkChief Technology Officer
|
GrantCommon Stock | 107,142 | $1.82 | $194,998.44 |
DisclosureSEC source: 0001214659-18-005741 · marketforms-42786.xml · nonDerivative · entry 1 Brister Mark · CIK 0001323223 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338,634 F1 · shares: The reporting person purchased these shares directly from the issuer in a private placement. F2 · balance_after: Includes Restricted Shares that are subject to vesting. Read SEC document |
| August 23, 2018 Filed Aug 28, 2018 01:32 UTC |
Rasdal Andrew PDirector · CEO
|
GrantCommon Stock | 109,890 | $1.82 | $199,999.80 |
DisclosureSEC source: 0001214659-18-005736 · marketforms-42783.xml · nonDerivative · entry 1 Rasdal Andrew P · CIK 0001323238 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 566,948 F1 · shares: The reporting person purchased these shares directly from the issuer in a private placement. Read SEC document |
| August 23, 2018 Filed Aug 28, 2018 01:32 UTC |
DITTAMORE RAYMOND VDirector
|
GrantCommon Stock | 27,472 | $1.82 | $49,999.04 |
DisclosureSEC source: 0001214659-18-005734 · marketforms-42793.xml · nonDerivative · entry 1 DITTAMORE RAYMOND V · CIK 0001203772 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,472 F1 · shares: The reporting person purchased these shares directly from the issuer in a private placement. Read SEC document |
| August 23, 2018 Filed Aug 28, 2018 01:31 UTC |
MONDORE ROBERT H JRVP of Operations
|
GrantCommon Stock | 13,736 | $1.82 | $24,999.52 |
DisclosureSEC source: 0001214659-18-005732 · marketforms-42792.xml · nonDerivative · entry 1 MONDORE ROBERT H JR · CIK 0001736056 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,736 F1 · shares: The reporting person purchased these shares directly from the issuer in a private placement. Read SEC document |
| August 23, 2018 Filed Aug 28, 2018 01:31 UTC |
MOATAZEDI DAVIDDirector
|
GrantCommon Stock | 5,494 | $1.82 | $9,999.08 |
DisclosureSEC source: 0001214659-18-005733 · marketforms-42795.xml · nonDerivative · entry 1 MOATAZEDI DAVID · CIK 0001700836 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,494 F1 · shares: The reporting person purchased these shares directly from the issuer in a private placement. Read SEC document |
| August 23, 2018 Filed Aug 27, 2018 21:38 UTC |
Kamdar Kim P.Director
|
PurchaseCommon Stock | 54,945 | $1.82 | $99,999.90 |
DisclosureSEC source: 0000904454-18-000528 · edgar.xml · nonDerivative · entry 1 Kamdar Kim P. · CIK 0001535065 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,345 F1 · ownership.direct: Includes 13,400 shares held jointly with the Reporting Person's mother. The Reporting Person disclaims beneficial ownership of such shares except to the extent of her pecuniary interest, if any, therein. Read SEC document |
| June 13, 2018 Filed Jun 14, 2018 19:53 UTC |
Stevenson SharonDirector
|
GrantStock Option (Right to Buy) · Derivative | 81,774 | $0.00 Strike: $2.36 | $0.00 |
DisclosureSEC source: 0001214659-18-004469 · marketforms-42280.xml · derivative · entry 1 Stevenson Sharon · CIK 0001683904 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,774 Underlying: Common Stock · 81,774 shares Expires 2028-06-13 F1 · derivative.exercise_date: This Option becomes exercisable with respect to 100% of the Shares subject to this Option on the earlier of (i) the one-year anniversary of the Date of Grant or (ii) the date of the annual meeting of the Company's stockholders immediately following the Date of Grant. Read SEC document |
| June 13, 2018 Filed Jun 14, 2018 23:52 UTC |
SHACKNAI JONAHDirector
|
GrantStock Option (Right to Buy) · Derivative | 81,774 | $0.00 Strike: $2.36 | $0.00 |
DisclosureSEC source: 0001214659-18-004468 · marketforms-42278.xml · derivative · entry 1 SHACKNAI JONAH · CIK 0001257575 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,774 Underlying: Common Stock · 81,774 shares Expires 2028-06-13 F1 · derivative.exercise_date: This Option becomes exercisable with respect to 100% of the Shares subject to this Option on the earlier of (i) the one-year anniversary of the Date of Grant or (ii) the date of the annual meeting of the Company's stockholders immediately following the Date of Grant. Read SEC document |
| June 13, 2018 Filed Jun 14, 2018 23:52 UTC |
HOWE LESLEY HDirector
|
GrantStock Option (Right to Buy) · Derivative | 81,774 | $0.00 Strike: $2.36 | $0.00 |
DisclosureSEC source: 0001214659-18-004467 · marketforms-42274.xml · derivative · entry 1 HOWE LESLEY H · CIK 0001222606 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,774 Underlying: Common Stock · 81,774 shares Expires 2028-06-13 F1 · derivative.exercise_date: This Option becomes exercisable with respect to 100% of the Shares subject to this Option on the earlier of (i) the one-year anniversary of the Date of Grant or (ii) the date of the annual meeting of the Company's stockholders immediately following the Date of Grant. Read SEC document |
| June 13, 2018 Filed Jun 14, 2018 23:52 UTC |
Fisher Douglas CarlDirector
|
GrantStock Option (Right to Buy) · Derivative | 81,774 | $0.00 Strike: $2.36 | $0.00 |
DisclosureSEC source: 0001214659-18-004466 · marketforms-42273.xml · derivative · entry 1 Fisher Douglas · CIK 0001572355 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,774 Underlying: Common Stock · 81,774 shares Expires 2028-06-13 F1 · derivative.exercise_date: This Option becomes exercisable with respect to 100% of the Shares subject to this Option on the earlier of (i) the one-year anniversary of the Date of Grant or (ii) the date of the annual meeting of the Company's stockholders immediately following the Date of Grant. Read SEC document |
| June 13, 2018 Filed Jun 14, 2018 23:52 UTC |
DITTAMORE RAYMOND VDirector
|
GrantStock Option (Right to Buy) · Derivative | 81,774 | $0.00 Strike: $2.36 | $0.00 |
DisclosureSEC source: 0001214659-18-004465 · marketforms-42272.xml · derivative · entry 1 DITTAMORE RAYMOND V · CIK 0001203772 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,774 Underlying: Common Stock · 81,774 shares Expires 2028-06-13 F1 · derivative.exercise_date: This Option becomes exercisable with respect to 100% of the Shares subject to this Option on the earlier of (i) the one-year anniversary of the Date of Grant or (ii) the date of the annual meeting of the Company's stockholders immediately following the Date of Grant. Read SEC document |
| June 13, 2018 Filed Jun 14, 2018 23:51 UTC |
MOATAZEDI DAVIDDirector
|
GrantStock Option (Right to Buy) · Derivative | 81,774 | $0.00 Strike: $2.36 | $0.00 |
DisclosureSEC source: 0001214659-18-004464 · marketforms-42277.xml · derivative · entry 1 MOATAZEDI DAVID · CIK 0001700836 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,774 Underlying: Common Stock · 81,774 shares Expires 2028-06-13 F1 · derivative.exercise_date: This Option becomes exercisable with respect to 100% of the Shares subject to this Option on the earlier of (i) the one-year anniversary of the Date of Grant or (ii) the date of the annual meeting of the Company's stockholders immediately following the Date of Grant. Read SEC document |
| June 13, 2018 Filed Jun 15, 2018 21:51 UTC |
Kamdar Kim P.Director
|
GrantStock Option (Right to Buy) · Derivative | 81,774 | $0.00 Strike: $2.36 | $0.00 |
DisclosureSEC source: 0000904454-18-000426 · edgar.xml · derivative · entry 1 Kamdar Kim P. · CIK 0001535065 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,774 Underlying: Common Stock · 81,774 shares Expires 2028-06-13 F1 · derivative.exercise_date: The option vests as to 100% of the total shares on June 13, 2019, or the date of the Issuer's 2019 Annual Meeting, if sooner. Read SEC document |
| June 13, 2018 Filed Aug 29, 2018 20:58 UTC Amendment |
MOATAZEDI DAVIDDirector
|
GrantStock Option (Right to Buy) · Derivative | 81,774 | $0.00 Strike: $2.36 | $0.00 |
DisclosureSEC source: 0001214659-18-005787 · marketforms-42814.xml · derivative · entry 1 MOATAZEDI DAVID · CIK 0001700836 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,774 Underlying: Common Stock · 81,774 shares Expires 2028-06-13 F1 · derivative.exercise_date: This amended Form 4 is being filed solely to attach a Power of Attorney for the Reporting Person that was inadvertently omitted from the original Form 4 filing. Reference is made to the original filing for the option vesting terms Read SEC document |
| May 15, 2018 Filed May 17, 2018 19:18 UTC |
Drake NeilVP Research and Development
|
GrantCommon Stock (Restricted Stock Award) | 17,938 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-18-003872 · marketforms-42035.xml · nonDerivative · entry 1 Drake Neil · CIK 0001698005 · VP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,938 F1 · shares: The Restricted Shares shall vest as to 100% of the Shares underlying the Award on January 2, 2020, subject to the reporting person's provision of service to the Issuer. Read SEC document |
| May 15, 2018 Filed May 17, 2018 19:20 UTC |
Young Donald RVP of Quality Assurance
|
GrantCommon Stock (Restricted Stock Award) | 20,377 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-18-003876 · marketforms-42034.xml · nonDerivative · entry 1 Young Donald R · CIK 0001686152 · VP of Quality Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,377 F1 · shares: The Restricted Shares shall vest as to 100% of the Shares underlying the Award on January 2, 2020, subject to the reporting person's provision of service to the Issuer. Read SEC document |
| May 15, 2018 Filed May 17, 2018 19:19 UTC |
Hussainy NooshinVP of Finance
|
GrantCommon Stock (Restricted Stock Award) | 21,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-18-003875 · marketforms-42033.xml · nonDerivative · entry 1 Hussainy Nooshin · CIK 0001685634 · VP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,875 F1 · shares: The Restricted Shares shall vest as to 100% of the Shares underlying the Award on January 2, 2020, subject to the reporting person's provision of service to the Issuer. Read SEC document |
| May 15, 2018 Filed May 17, 2018 23:18 UTC |
Plovanic William J.Chief Financial Officer
|
GrantCommon Stock (Restricted Stock Award) | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-18-003871 · marketforms-42031.xml · nonDerivative · entry 1 Plovanic William J. · CIK 0001685640 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 F1 · shares: The Restricted Shares shall vest as to 100% of the Shares underlying the Award on January 2, 2020, subject to the reporting person's provision of service to the Issuer. Read SEC document |
| May 15, 2018 Filed May 17, 2018 19:19 UTC |
VandenBerg AmyVP of Reg. and Clin. Affairs
|
GrantCommon Stock (Restricted Stock Award) | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-18-003873 · marketforms-42032.xml · nonDerivative · entry 1 VandenBerg Amy · CIK 0001685638 · VP of Reg. and Clin. Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 F1 · shares: The Restricted Shares shall vest as to 100% of the Shares underlying the Award on January 2, 2020, subject to the reporting person's provision of service to the Issuer. Read SEC document |
| May 15, 2018 Filed May 17, 2018 23:19 UTC |
Huang KellyChief Operating Officer
|
GrantCommon Stock (Restricted Stock Award) | 65,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-18-003874 · marketforms-42030.xml · nonDerivative · entry 1 Huang Kelly · CIK 0001602803 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 F1 · shares: The Restricted Shares shall vest as to 100% of the Shares underlying the Award on January 2, 2020, subject to the reporting person's provision of service to the Issuer. Read SEC document |
| May 07, 2018 Filed May 9, 2018 19:45 UTC |
Wood Todd MichaelVice President of Sales
|
GrantStock Option (Right to Buy) · Derivative | 80,000 | $0.00 Strike: $4.30 | $0.00 |
DisclosureSEC source: 0001214659-18-003526 · marketforms-41959.xml · derivative · entry 1 Wood Todd Michael · CIK 0001739840 · Vice President of Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common · 80,000 shares Expires 2028-05-07 F1 · derivative.exercise_date: The Option shall vest as to one-fourth of the Shares underlying the Option on the first anniversary of the vesting commencement date and as to 1/48th of the Shares underlying the Option on each monthly anniversary of the vesting commencement Date thereafter, subject to the grantee's continued status as a Service Provider with the Company through the applicable vesting date. Read SEC document |
| April 30, 2018 Filed May 2, 2018 07:23 UTC |
Drake NeilVP Research and Development
|
GrantCommon Stock | 2,743 | $3.27 | $8,969.61 |
DisclosureSEC source: 0001214659-18-003244 · marketforms-41862.xml · nonDerivative · entry 1 Drake Neil · CIK 0001698005 · VP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,593 F1 · kind: These shares were acquired under the Obalon Therapeutics, Inc. 2016 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| April 30, 2018 Filed May 2, 2018 11:23 UTC |
Rasdal Andrew PDirector · President & CEO
|
GrantCommon Stock | 2,987 | $3.27 | $9,767.49 |
DisclosureSEC source: 0001214659-18-003245 · marketforms-41863.xml · nonDerivative · entry 1 Rasdal Andrew P · CIK 0001323238 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 457,058 F1 · kind: These shares were acquired under the Obalon Therapeutics, Inc. 2016 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| April 30, 2018 Filed May 2, 2018 11:23 UTC |
Brister MarkChief Technology Officer
|
GrantCommon Stock | 2,622 | $3.27 | $8,573.94 |
DisclosureSEC source: 0001214659-18-003243 · marketforms-41861.xml · nonDerivative · entry 1 Brister Mark · CIK 0001323223 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,492 F1 · kind: These shares were acquired under the Obalon Therapeutics, Inc. 2016 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 21:12 UTC |
MONDORE ROBERT H JRVP of Operations
|
GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $3.55 | $0.00 |
DisclosureSEC source: 0001214659-18-002645 · marketforms-41725.xml · derivative · entry 1 MONDORE ROBERT H JR · CIK 0001736056 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2028-04-02 F1 · derivative.exercise_date: The Option shall vest as to one-fourth of the Shares underlying the Option on April 2, 2019, and as to 1/48th of the Shares underlying the Option on each monthly anniversary thereafter, subject to the Reporting Person's continued status as a Service Provider with the Company through the applicable vesting date. Read SEC document |
| March 15, 2018 Filed Mar 19, 2018 17:27 UTC |
Drake NeilVP Research and Development
|
PurchaseCommon Stock | 5,000 | $3.96 | $19,777.50 |
DisclosureSEC source: 0001214659-18-002236 · marketforms-41517.xml · nonDerivative · entry 1 Drake Neil · CIK 0001698005 · VP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,850 Read SEC document |
| March 14, 2018 Filed Mar 15, 2018 22:15 UTC |
Plovanic William J.Chief Financial Officer
|
PurchaseCommon Stock | 5,412 | $4.04 | $21,842.83 |
DisclosureSEC source: 0001214659-18-002171 · marketforms-41497.xml · nonDerivative · entry 4 Plovanic William J. · CIK 0001685640 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By wife IRA Disclosed balance after: 15,000 F2 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $3.99 to $4.05, inclusive. Read SEC document |
| March 14, 2018 Filed Mar 15, 2018 22:15 UTC |
Plovanic William J.Chief Financial Officer
|
PurchaseCommon Stock | 5,300 | $4.04 | $21,386.56 |
DisclosureSEC source: 0001214659-18-002171 · marketforms-41497.xml · nonDerivative · entry 2 Plovanic William J. · CIK 0001685640 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By IRA Disclosed balance after: 15,000 F2 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $3.99 to $4.05, inclusive. Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 22:15 UTC |
Plovanic William J.Chief Financial Officer
|
PurchaseCommon Stock | 9,588 | $4.05 | $38,824.69 |
DisclosureSEC source: 0001214659-18-002171 · marketforms-41497.xml · nonDerivative · entry 3 Plovanic William J. · CIK 0001685640 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By wife IRA Disclosed balance after: 9,588 F1 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $4.015 to $4.05, inclusive. Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 22:15 UTC |
Plovanic William J.Chief Financial Officer
|
PurchaseCommon Stock | 9,700 | $4.05 | $39,276.27 |
DisclosureSEC source: 0001214659-18-002171 · marketforms-41497.xml · nonDerivative · entry 1 Plovanic William J. · CIK 0001685640 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By IRA Disclosed balance after: 9,700 F1 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $4.015 to $4.05, inclusive. Read SEC document |
| February 02, 2018 Filed Feb 5, 2018 19:14 UTC |
Drake NeilVP Research and Development
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,310 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0001214659-18-000895 · marketforms-40926.xml · derivative · entry 8 Drake Neil · CIK 0001698005 · VP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,034 Underlying: Common Stock · 4,310 shares Expires 2026-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option vests as to 2.083% of the total shares monthly, commencing on May 11, 2016, with 100% of the total shares vested on May 11, 2020, subject to the reporting person's provision of service to the Issuer on each vesting date. Read SEC document |
| February 02, 2018 Filed Feb 5, 2018 19:14 UTC |
Drake NeilVP Research and Development
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,641 | $0.00 Strike: $0.76 | $0.00 |
DisclosureSEC source: 0001214659-18-000895 · marketforms-40926.xml · derivative · entry 7 Drake Neil · CIK 0001698005 · VP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,083 Underlying: Common Stock · 3,641 shares Expires 2025-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option vests as to 25% of the total shares on January 1, 2016, then 2.083% monthly, with 100% of the total shares vested on January 1, 2019, subject to the reporting person's provision of service to the Issuer on each vesting date. Read SEC document |
| February 02, 2018 Filed Feb 5, 2018 19:14 UTC |
Drake NeilVP Research and Development
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,746 | $0.00 Strike: $1.83 | $0.00 |
DisclosureSEC source: 0001214659-18-000895 · marketforms-40926.xml · derivative · entry 6 Drake Neil · CIK 0001698005 · VP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,746 shares Expires 2022-08-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2018 Filed Feb 5, 2018 19:14 UTC |
Drake NeilVP Research and Development
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 229 | $0.00 Strike: $1.31 | $0.00 |
DisclosureSEC source: 0001214659-18-000895 · marketforms-40926.xml · derivative · entry 5 Drake Neil · CIK 0001698005 · VP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 229 shares Expires 2021-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2018 Filed Feb 5, 2018 19:14 UTC |
Drake NeilVP Research and Development
|
Exercise / conversionCommon Stock | 4,310 | $1.77 | $7,628.70 |
DisclosureSEC source: 0001214659-18-000895 · marketforms-40926.xml · nonDerivative · entry 4 Drake Neil · CIK 0001698005 · VP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,850 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2018 Filed Feb 5, 2018 19:14 UTC |
Drake NeilVP Research and Development
|
Exercise / conversionCommon Stock | 3,641 | $0.76 | $2,767.16 |
DisclosureSEC source: 0001214659-18-000895 · marketforms-40926.xml · nonDerivative · entry 3 Drake Neil · CIK 0001698005 · VP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,540 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2018 Filed Feb 5, 2018 19:14 UTC |
Drake NeilVP Research and Development
|
Exercise / conversionCommon Stock | 5,746 | $1.83 | $10,515.18 |
DisclosureSEC source: 0001214659-18-000895 · marketforms-40926.xml · nonDerivative · entry 2 Drake Neil · CIK 0001698005 · VP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,899 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2018 Filed Feb 5, 2018 19:14 UTC |
Drake NeilVP Research and Development
|
Exercise / conversionCommon Stock | 229 | $1.31 | $299.99 |
DisclosureSEC source: 0001214659-18-000895 · marketforms-40926.xml · nonDerivative · entry 1 Drake Neil · CIK 0001698005 · VP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,153 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2018 Filed Jan 30, 2018 18:47 UTC |
VandenBerg AmyVP of Reg. and Clin. Affairs
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,541 | $0.00 Strike: $1.31 | $0.00 |
DisclosureSEC source: 0001214659-18-000757 · marketforms-40861.xml · derivative · entry 6 VandenBerg Amy · CIK 0001685638 · VP of Reg. and Clin. Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,541 shares Expires 2021-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2018 Filed Jan 30, 2018 18:47 UTC |
VandenBerg AmyVP of Reg. and Clin. Affairs
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,087 | $0.00 Strike: $0.87 | $0.00 |
DisclosureSEC source: 0001214659-18-000757 · marketforms-40861.xml · derivative · entry 5 VandenBerg Amy · CIK 0001685638 · VP of Reg. and Clin. Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,087 shares Expires 2020-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2018 Filed Jan 30, 2018 18:47 UTC |
VandenBerg AmyVP of Reg. and Clin. Affairs
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,022 | $0.00 Strike: $0.87 | $0.00 |
DisclosureSEC source: 0001214659-18-000757 · marketforms-40861.xml · derivative · entry 4 VandenBerg Amy · CIK 0001685638 · VP of Reg. and Clin. Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,022 shares Expires 2018-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2018 Filed Jan 30, 2018 18:47 UTC |
VandenBerg AmyVP of Reg. and Clin. Affairs
|
Exercise / conversionCommon Stock | 1,541 | $1.31 | $2,018.71 |
DisclosureSEC source: 0001214659-18-000757 · marketforms-40861.xml · nonDerivative · entry 3 VandenBerg Amy · CIK 0001685638 · VP of Reg. and Clin. Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,650 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2018 Filed Jan 30, 2018 18:47 UTC |
VandenBerg AmyVP of Reg. and Clin. Affairs
|
Exercise / conversionCommon Stock | 1,087 | $0.87 | $945.69 |
DisclosureSEC source: 0001214659-18-000757 · marketforms-40861.xml · nonDerivative · entry 2 VandenBerg Amy · CIK 0001685638 · VP of Reg. and Clin. Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,109 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2018 Filed Jan 30, 2018 18:47 UTC |
VandenBerg AmyVP of Reg. and Clin. Affairs
|
Exercise / conversionCommon Stock | 4,022 | $0.87 | $3,499.14 |
DisclosureSEC source: 0001214659-18-000757 · marketforms-40861.xml · nonDerivative · entry 1 VandenBerg Amy · CIK 0001685638 · VP of Reg. and Clin. Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,022 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 16:11 UTC |
Drake NeilVP Research and Development
|
GrantStock Option (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $7.15 | $0.00 |
DisclosureSEC source: 0001214659-18-000186 · marketforms-40639.xml · derivative · entry 1 Drake Neil · CIK 0001698005 · VP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2028-01-02 F1 · derivative.exercise_date: The Option shall vest as to 1/48th of the Shares underlying the Option on each monthly anniversary of the Grant Date, subject to the grantee's continued status as a Service Provider with the Company through the applicable vesting date. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 16:15 UTC |
Young Donald RVP of Quality Assurance
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $7.15 | $0.00 |
DisclosureSEC source: 0001214659-18-000190 · marketforms-40652.xml · derivative · entry 1 Young Donald R · CIK 0001686152 · VP of Quality Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2028-01-02 F1 · derivative.exercise_date: The Option shall vest as to 1/48th of the Shares underlying the Option on each monthly anniversary of the Grant Date, subject to the grantee's continued status as a Service Provider with the Company through the applicable vesting date. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 16:18 UTC |
Metzner LisaVP of Marketing
|
GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $7.15 | $0.00 |
DisclosureSEC source: 0001214659-18-000193 · marketforms-40648.xml · derivative · entry 1 Metzner Lisa · CIK 0001685641 · VP of Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2028-01-02 F1 · derivative.exercise_date: The Option shall vest as to 1/48th of the Shares underlying the Option on each monthly anniversary of the Grant Date, subject to the grantee's continued status as a Service Provider with the Company through the applicable vesting date. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 16:16 UTC |
Norwood MatthewVP of Sales
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $7.15 | $0.00 |
DisclosureSEC source: 0001214659-18-000191 · marketforms-40643.xml · derivative · entry 1 Norwood Matthew · CIK 0001685642 · VP of Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2028-01-02 F1 · derivative.exercise_date: The Option shall vest as to 1/48th of the Shares underlying the Option on each monthly anniversary of the Grant Date, subject to the grantee's continued status as a Service Provider with the Company through the applicable vesting date. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 16:14 UTC |
Hussainy NooshinVP of Finance
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $7.15 | $0.00 |
DisclosureSEC source: 0001214659-18-000189 · marketforms-40640.xml · derivative · entry 1 Hussainy Nooshin · CIK 0001685634 · VP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2028-01-02 F1 · derivative.exercise_date: The Option shall vest as to 1/48th of the Shares underlying the Option on each monthly anniversary of the Grant Date, subject to the grantee's continued status as a Service Provider with the Company through the applicable vesting date. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 16:09 UTC |
VandenBerg AmyVP of Reg. and Clin. Affairs
|
GrantCommon Stock (Restricted Stock Award) | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-18-000184 · marketforms-40651.xml · nonDerivative · entry 1 VandenBerg Amy · CIK 0001685638 · VP of Reg. and Clin. Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 F1 · shares: The Restricted Shares shall vest as to one-fourth of the Shares underlying the Award on each of the first, second, third and fourth anniversaries of the Grant Date, subject to the grantee's continued status as a Service Provider with the Company through the applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.